Graf Akcie HEPA (Hepion Pharmaceuticals Inc). Diskuze k akciím HEPA. Aktuální informace HEPA.

Základní informace o společnosti Hepion Pharmaceuticals Inc (Akcie HEPA)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace	117.39M
Hodnota podniku (EV)	N/A
Tržby	0.00
EBITDA	N/A
Zisk	-24.92
Růst v tržbách Q/Q	N/A %
Růst v tržbách Y/Y	N/A %
P/E (Cena vůči ziskům)	0.00
Forward P/E	-7.50
EV/Sales	N/A
EV/EBITDA	N/A
EV/EBIT	N/A
PEG	N/A
Price/Sales	N/A
P/FCF	N/A
Price/Book	2.86
Účetní hodnota na akcii	0.54
Hotovost na akcii	0.54
FCF vůči ceně	-18.18 %
Počet zaměstnanců	13
Tržba na zaměstnance	0.00
Profit margin	N/A %
Operating margin	N/A %
Gross margin	N/A %
EBIT margin	N/A %
EBITDA margin	N/A %

EPS - Zisk na akcii	N/A
EPS - Kvartální růst	-87.63 %
EPS - Očekávaný růst příští rok	-67.24 %
Return on assets	-31.88 %
Return on equity	-35.37 %
ROIC	-58.75 %
ROCE	-22.14 %
Dluhy/Equity	0.20
Čistý dluh/EBITDA	7.49
Current ratio	16.01
Quick Ratio	16.01
Volatilita	4.30
Beta	1.18
RSI	49.84
Cílová cena analytiků	13
Známka akcie (dle analytiků)	N/A
Insider ownership	0.15 %
Institutional ownership	21.54 %
Počet akcií	76.228M
Procento shortovaných akcií	2.62 %
Short ratio	1.10 %
Dividenda	N/A
Procentuální dividenda	N/A %
Dividenda/Zisk	N/A %
Obchodovaná od	2019
Země	United States

Finanční výsledky akcie HEPA

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

#	2020	2019	2018	2017	2016	2015
Revenue	-	-	-	-	-	-
Cost Of Goods Sold	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-
Research And Development Expenses	-	-	-	-	-	-
SG&A Expenses	$4.586	$7	$3.358	$7.372	$5.786	$5.556
Other Operating Income Or Expenses	-	-	-	-	-	-
Operating Expenses	$7.77	$14.594	$10.522	$21.024	$20.806	$13.96
Operating Income	$-7.77	$-14.594	$-10.522	$-21.024	$-20.806	$-13.96
Total Non-Operating Income/Expense	$-0.176	$4.609	$1.063	$4.225	$3.807	$-0.388
Pre-Tax Income	$-7.946	$-9.985	$-9.459	$-16.799	$-16.999	$-14.348
Income Taxes	$-1.227	$-0.536	$-1.948	$-1.908	-	-
Income After Taxes	$-6.719	$-9.449	$-7.511	$-14.891	$-16.999	$-14.348
Other Income	-	-	-	-	-	-
Income From Continuous Operations	$-6.719	$-9.449	$-7.511	$-14.891	$-16.999	$-14.348
Income From Discontinued Operations	-	-	-	-	-	-
Net Income	$-12.162	$-17.901	$-7.511	$-14.891	$-16.999	$-22.193
EBITDA	$-7.257	$-14.575	$-10.511	$-20.996	$-20.784	$-13.944
EBIT	$-7.77	$-14.594	$-10.522	$-21.024	$-20.806	$-13.96
Basic Shares Outstanding	2	0	0	0	0	0
Shares Outstanding	2	0	0	0	0	0
Basic EPS	$-5.95	$-97.35	$-54.55	$-142.66	$-352.45	$-570.63
EPS - Earnings Per Share	$-5.95	$-97.35	$-54.55	$-168.53	$-352.45	$-570.63

#	2020	2019	2018	2017	2016	2015
Cash On Hand	$13.923	$2.832	$5.954	$12.983	$7.404	$4.563
Receivables	-	-	-	-	-	-
Inventory	-	-	-	-	-	-
Pre-Paid Expenses	$0.466	$0.136	$0.108	$0.21	$0.491	$0.681
Other Current Assets	-	-	-	-	-	-
Total Current Assets	$14.389	$2.968	$6.062	$13.193	$7.895	$5.244
Property, Plant, And Equipment	$0.057	$0.032	$0.057	$0.068	$0.081	$0.081
Long-Term Investments	-	-	-	-	-	-
Goodwill And Intangible Assets	$1.871	$1.871	$1.871	$1.871	$1.871	-
Other Long-Term Assets	$3.318	$3.318	$3.263	$3.253	$3.26	$0.051
Total Long-Term Assets	$6.044	$5.221	$5.191	$5.192	$5.212	$0.133
Total Assets	$20.433	$8.189	$11.253	$18.385	$13.107	$5.377
Total Current Liabilities	$1.252	$2.85	$2.604	$2.945	$5.084	$1.938
Long Term Debt	-	-	-	-	-	-
Other Non-Current Liabilities	$2.436	$2.994	$4.05	$5.112	$5.436	-
Total Long Term Liabilities	$2.995	$3.364	$4.946	$6.382	$6.706	-
Total Liabilities	$4.247	$6.214	$7.55	$9.327	$11.789	$1.938
Common Stock Net	$0	-	$0.001	$0.008	$0.003	$0.002
Retained Earnings (Accumulated Deficit)	$-83.186	$-76.464	$-67.015	$-59.504	$-44.613	$-27.614
Comprehensive Income	-	-	-	-	-	-
Other Share Holders Equity	-	-	-	-	-	-
Share Holder Equity	$16.186	$1.975	$3.703	$9.058	$1.318	$3.439
Total Liabilities And Share Holders Equity	$20.433	$8.189	$11.253	$18.385	$13.107	$5.377

#	2020	2019	2018	2017	2016	2015
Net Income/Loss	$-6.719	$-9.449	$-7.511	$-14.891	$-16.999	$-14.348
Total Depreciation And Amortization - Cash Flow	$0.513	$0.019	$0.011	$0.028	$0.022	$0.016
Other Non-Cash Items	$-0.605	$-5.245	$-0.69	$-2.468	$-2.905	$3.706
Total Non-Cash Items	$-0.092	$-5.226	$-0.679	$-2.44	$-2.884	$3.722
Change In Accounts Receivable	-	-	-	-	-	-
Change In Inventories	-	-	-	-	-	-
Change In Accounts Payable	-	-	-	-	-	-
Change In Assets/Liabilities	$-0.33	$-0.073	$0.092	$0.288	$0.192	$-0.564
Total Change In Assets/Liabilities	$-0.755	$-0.971	$-0.019	$-1.841	$3.327	$0.953
Cash Flow From Operating Activities	$-7.565	$-15.646	$-8.209	$-19.172	$-16.555	$-9.673
Net Change In Property, Plant, And Equipment	$-0.052	$0.001	-	$-0.015	$-0.007	$-0.083
Net Change In Intangible Assets	-	-	-	-	-	-
Net Acquisitions/Divestitures	-	-	-	-	$-0.496	-
Net Change In Short-term Investments	-	-	-	-	-	-
Net Change In Long-Term Investments	-	-	-	-	-	-
Net Change In Investments - Total	-	-	-	-	-	-
Investing Activities - Other	-	-	-	-	-	-
Cash Flow From Investing Activities	$-0.052	$0.001	-	$-0.015	$-0.502	$-0.083
Net Long-Term Debt	$-1.119	-	-	-	-	-
Net Current Debt	-	-	-	$-0.01	-	-
Debt Issuance/Retirement Net - Total	$-1.119	-	-	$-0.01	-	-
Net Common Equity Issued/Repurchased	$19.827	$1.778	$1.181	$24.776	$19.898	$0.001
Net Total Equity Issued/Repurchased	$19.827	$12.193	$1.181	$24.776	$19.898	$12.501
Total Common And Preferred Stock Dividends Paid	-	-	-	-	-	-
Financial Activities - Other	-	$0.331	-	-	-	-
Cash Flow From Financial Activities	$18.707	$12.524	$1.181	$24.766	$19.898	$12.501
Net Cash Flow	$11.091	$-3.122	$-7.029	$5.579	$2.841	$2.745
Stock-Based Compensation	-	-	$0.746	$1.7	$0.902	$2.118
Common Stock Dividends Paid	-	-	-	-	-	-

#	2020	2019	2018	2017	2016	2015
Current Ratio	11.4936	1.0415	2.3284	4.48	1.553	2.7059
Long-term Debt / Capital	-	-	-	-	-	-
Debt/Equity Ratio	-	0.7291	-	-	0.0079	-
Gross Margin	-	-	-	-	-	-
Operating Margin	-	-	-	-	-	-
EBIT Margin	-	-	-	-	-	-
EBITDA Margin	-	-	-	-	-	-
Pre-Tax Profit Margin	-	-	-	-	-	-
Net Profit Margin	-	-	-	-	-	-
Asset Turnover	-	-	-	-	-	-
Inventory Turnover Ratio	-	-	-	-	-	-
Receiveable Turnover	-	-	-	-	-	-
Days Sales In Receivables	-	-	-	-	-	-
ROE - Return On Equity	-46.4456	-5001.365	-282.0511	-185.7264	137.2804	139.8304
Return On Tangible Equity	-46.9358	-9074.785	-409.942	-207.1959	3071.985	-417.2005
ROA - Return On Assets	-32.8822	-115.3877	-66.7481	-80.9975	-129.6941	-266.8281
ROI - Return On Investment	-41.5104	-478.433	-202.8294	-164.3991	-1290.141	-417.2005
Book Value Per Share	4.3047	7.9962	26.4463	66.9336	22.8695	86.3655
Operating Cash Flow Per Share	81.3299	-25.7152	124.5424	158.4014	-93.5268	-189.2431
Free Cash Flow Per Share	81.2998	-25.7103	124.6834	158.3969	-91.522	-190.6928

Warning: Undefined array key "user" in /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/views/stock.php on line 716

Fatal error: Uncaught mysqli_sql_exception: You have an error in your SQL syntax; check the manual that corresponds to your MariaDB server version for the right syntax to use near 'AND valid >= CURDATE()' at line 2 in /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/php/classes/Database.php:11 Stack trace: #0 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/php/classes/Database.php(11): mysqli_query(Object(mysqli), 'SELECT * FROM p...') #1 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/views/stock.php(716): Database::Execute(Object(mysqli), 'SELECT * FROM p...') #2 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/routes.php(20): require_once('/data/web/virtu...') #3 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/php/classes/Route.php(8): {closure}() #4 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/php/classes/Route.php(8): Closure->__invoke() #5 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/routes.php(21): Route::set('graf-akcie/HEPA', Object(Closure)) #6 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/index.php(23): require_once('/data/web/virtu...') #7 {main} thrown in /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/php/classes/Database.php on line 11

JenAkcie

Graf Akcie HEPA (Hepion Pharmaceuticals Inc). Diskuze k akciím HEPA. Aktuální informace HEPA.

Základní informace o společnosti Hepion Pharmaceuticals Inc (Akcie HEPA)

Finanční výsledky akcie HEPA